|Articles|August 13, 2008
Viread now also approved to treat hepatitis B
The drug is administered as a once-daily tablet.
Advertisement
The anti-HIV drug Viread (tenofovir disoproxil fumarate, Gilead Sciences) has gained a new indication: to treat chronic hepatitis B in adults. Administered as a once-daily tablet, the
To see more Daily News articles,